Oseltamivir-Resistant Novel Influenza A (H1N1) Virus Infection

Article

The MMWR Dispatch (Vol. 58) is reporting that on Aug. 6, 2009, the Centers for Disease Control and Prevention (CDC) detected evidence of resistance to the antiviral medication oseltamivir by pyrosequencing viral RNA from clinical specimens of two immunosuppressed patients with novel influenza A (H1N1) virus infection in Seattle. This report summarizes the case histories and resulting investigations and highlights the importance of close monitoring for antiviral drug resistance among immunosuppressed patients receiving treatment for novel influenza A (H1N1) virus infection, plus the implications for infection prevention and control. To read the full report from the MMWR, CLICK HERE.

Recent Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content
Silhouette for internal organs of heart (Adobe Stock 765185323 by NikahGeh by AI)

Infection Prevention Implication for Organ Donation Program

Rebecca Leach, MPH, BSN, RN, CIC
July 26th 2024
Article

Transplants are a crucial yet complex part of acute care. They involve various organs and tissues, necessitating robust infection prevention programs and compliance with strict regulatory standards.

IP LifeLine From Infection Control Today

IP LifeLine: Keeping it Together When Things Fall Apart: Maintaining Balance When Life Gets Messy

Brenna Doran, PhD, MA, ACC, CIC
July 25th 2024
Article

Balancing personal struggles and professional responsibilities during crises requires self-awareness, self-compassion, healthy boundaries, and support networks. Embrace these strategies to navigate and overcome challenges.

Precision manufacturing of surgical instruments. (Adobe Stock 882881942 by Ilja with AI)

Enhancing Infection Prevention in Medical Devices Through Quality Systems

Eliza Johnson, BS, CRCST
July 24th 2024
Article

Utilizing robust quality systems is essential in medical device manufacturing to prevent infections and extend the lifespan of instruments, ensuring optimal patient safety.

World Hepatitis Day (Adobe Stock 797793741 by Art & Stock)

World Hepatitis Day: The Fight Continues

Thelma King Thiel, BA, RN
July 23rd 2024
Article

This Sunday, July 28, is World Hepatitis Day, a time to raise awareness and support research for infection prevention and treatment.

COVID-19 blue and green vector typography banner with virus symbol (Adobe Stock 331001452 by Web Buttons Inc)

Reevaluating the 6-Foot Rule: Efficacy and Challenges in COVID-19 Prevention

Kevin Kavanagh, MD
July 22nd 2024
Article

The June 3, 2024, House Oversight Committee questioned the efficacy of the six-foot social distancing rule, highlighting its benefits and limitations in preventing the spread of COVID-19.

Weekly Rounds: Antimicrobial Resistant Gonorrhea, CDC Speaks to ICT, and More

Weekly Rounds: Antimicrobial Resistant Gonorrhea, CDC Speaks to ICT, and More

July 19th 2024
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 20, 2024.